Get notified when PRPH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Class Action Lawsuit (new) — A subsidiary faces a class action alleging improper sharing of genetic information, though management deems it immaterial.
- Ceased Operations (new) — The prior auditor is unavailable to consent, which is unusual and may raise questions about continuity of audit oversight.
ProPhase Labs files to sell up to $5.29M of stock at $0.11/share, potentially tripling shares outstanding
Filed December 29, 2025 · ~2 min read
Key Changes
-
high
Offering of up to $5,289,599.84 of common stock at $0.11 per share, the Dec. 17, 2025 closing price. All proceeds go to the company.
The Offering verify on EDGAR → -
high
Shares outstanding could rise from 41.9M to 108.3M, a 159% increase, causing significant dilution for existing holders.
The Offering verify on EDGAR → -
high
New investors face immediate dilution of $0.10 per share in net tangible book value.
Dilution verify on EDGAR →
6 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (IPW 10-K) is open in full — no account needed.
Partner
Trade PRPH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify